E X Chen

Statistics

Publications

Citations

135

H-Index

Active since

2011

Affiliations

Juravinski Cancer Centre(Current)

Princess Margaret Cancer Centre

E X Chen is an author at Juravinski Cancer Centre specializing in dose-limiting toxicity assessment, recommended phase ii dose, and pharmacodynamics of anticancer drugs.

Publications per year

2011–2014

Publications

A Phase I study of cyclin-dependent kinase inhibitor, AT7519, in patients with advanced cancer: NCIC Clinical Trials Group IND 177

E X Chen, Sebastién J. Hotte, Hal W. Hirte et al. · British Journal of Cancer · 2014 · 69 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours

A.R. Abdul Razak, Sebastién J. Hotte, Lillian L. Siu et al. · British Journal of Cancer · 2011 · 66 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

1–2 of 2